Clinical Trials Logo

Filter by:
NCT ID: NCT02939430 Recruiting - Clinical trials for Blood Coagulation Tests ( INR, APTT)

Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding

Suga_bleeding
Start date: November 2016
Phase: N/A
Study type: Interventional

Sugammadex is new drug that is used for reversal of rocuronium induced muscle relaxation. benefits of reversal of neuromuscular blockade appears to be of great value in living donor liver transplant recipients. However, Few Clinical reports have investigated the anticoagulant effect of sugammadex. In this study, effects of sugammadex on bleeding profile of living donor liver transplantation will be investigated.

NCT ID: NCT02939196 Recruiting - Clinical trials for Pain Associated Office Hysteroscopy

Pain in Different Office Hysteroscopy Diameter

Start date: November 2016
Phase: N/A
Study type: Observational

The purpose of the investigators'study was To compare 2 different diameter rigid hysteroscopy in vaginoscopic approach regarding pain during and after the procedure. And to evaluate patient acceptability and tolerability in order to determine the best way to perform hysteroscopy in an outpatient setting.

NCT ID: NCT02937792 Recruiting - Spinal Anesthesia Clinical Trials

Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section

Start date: October 2016
Phase: N/A
Study type: Interventional

To test the safety of high dose spinal in elective CS after prolonged sitting position.

NCT ID: NCT02923661 Recruiting - Dental Implant Clinical Trials

Patient Satisfaction in Single Implant Mandibular Complete Overdentures Retained by CM LOC Versus Ball Attachment

Start date: February 2016
Phase: N/A
Study type: Interventional

this study was conducted to clarify the effect of two different attachments on patient satisfaction and marginal bone loss. The primary and secondary objectives are to determine patient satisfaction and the marginal bone loss around implant when using CM LOC compared to conventional ball attachment. all the patients will receive a single median implant to which the denture will be loaded upon using the two different attachment systems

NCT ID: NCT02918760 Recruiting - Pelvic Pain Clinical Trials

Oral Gabapentin in Management of Chronic Pelvic Pain in Females: A Randomised Placebo-controlled Study.

Start date: March 2016
Phase: Phase 3
Study type: Interventional

Aim :The aim of this study is to evaluate the efficacy of oral Gabapentin in the treatment of chronic pelvic pain in females. The study is designed as a randomised, placebo-controlled, clinical trial.32 patients will be enrolled each arm. Group A (cases): This group will include (32) women according to inclusion and exclusion criteria and will receive a card of Gabapentin which will be taken orally by the patient at home three times daily and maximum dose 2700mg per day by 300 mg increments each week until sufficient pain relief, or the occurrence of side effects such as dizziness, somnolence, edema and ataxia. Group B (controls):This group will include (32) women . Assessment of the patient's pain during the physical examination will be done using the Visual Analogue Scale (VAS). The patient will be asked to place a mark on a drawn 10 cm line at a point which is corresponding to the intensity of her pain. One end of the line denotes no pain and the other end of the line indicates that pain is as bad as it can be (the worst pain).the distance in cm from the low end of VAS to the patient's mark will be used (it gives a number.Questionnaire: will be given to all participants at randomization (0 months) , at 3 months and at 6 months to assess the degree of pain improvement via VAS. Patients' overall satisfaction with their pain treatment &Side effect recording (e.g., dizziness, somnolence, mood changes, appetite and poor concentration).

NCT ID: NCT02916069 Recruiting - Clinical trials for Intraoperative Neurophysiological Monitoring

Multi Modal Brain Monitoring and Cardiac Surgery

Start date: September 2016
Phase: N/A
Study type: Interventional

Multimodal brain monitoring is feasible and can be used in formulating therapeutic strategies during cardiac surgery. Such monitoring may help to improve patient outcome and to reduce costs after cardiac surgery with CPB.

NCT ID: NCT02907515 Recruiting - Clinical trials for Completely Edentulous

Maintenance and Cost Effectiveness of Cendres Metaux Locator (CM-LOC) Resin Matrix Versus Ball Nylon Matrix Attachment Retaining Single Implant Mandibular Complete Overdentures

MCRB
Start date: February 2016
Phase: N/A
Study type: Interventional

The single implant overdenture (IOD) represent the simplest form of IODs compared to the 2 IOD which is the traditional gold standard IOD treatment option. Mandibular single-implant overdentures are proven to be a successful treatment option for older edentulous adults but we need to know if the CM-LOC attachment will retain its superiority over the ball attachments intraorally regarding the prosthetic complications in single implant retained overdenture like in 2 IOD

NCT ID: NCT02901639 Recruiting - Clinical trials for Improving Quality of Life

Postpartum Contraception Counseling on the Rate of Unintended Pregnancy

Start date: September 2016
Phase: N/A
Study type: Interventional

Unwanted pregnancies are not only the major cause of maternal mortality and morbidity but are also a great social and financial burden on societies and countries. According to World-health-organization statistics, there are an estimated 200 million pregnancies around the world each year, and a third of these, 75 million, are unwanted. Unintended pregnancy also is a major health problem in the United States of America. In the 2002 National Survey of Family Growth assessment, 1.22 million, or 31%, were reported as unintended. When abortions were included, unintended pregnancies increased to 2.65 million, or 49% of all pregnancies

NCT ID: NCT02896023 Recruiting - Ovarian Reserve Clinical Trials

Predictors of Ovarian Reserve in Infertile Women

Start date: September 2016
Phase: Phase 4
Study type: Interventional

Patients will be subjected to: A. Clinical evaluation including history and examination B. Ultrasonographic evaluation of Ovarian Morphometry: - Patients will be evaluated in early follicular phase of the menstrual flow (cycle's days 1-3) by TVS scanning; using MINDRAY DP-1100 Plus Digital Machine, 7.5MHz, China, by only one examiner to avoid inter-observer variations. - Ovarian images will be procured in the sagittal and coronal planes and the frozen image reflecting the largest ovarian dimensions will be utilized for the measurement of ovarian length, width, and height (cm) as per standard clinical practice. Mean values of both ovaries will be used. Ovarian volume will be calculated from ellipsoid volume formula, {Ovarian volume = Ovarian Width (D1) × Ovarian Length (D2) ×Ovarian Height (D3) × 0 .523} - Antral follicle count will be determined for each patient C. Laboratory Evaluation: Blood samples will be collected in the early follicular phase. Samples will be immediately centrifuged and serum saved at -20 degrees for measurement of: - Anti Mullerian Hormone (AMH) - Follicle Stimulating Hormone (FSH) - Estradiol (E2) Using electro-chemiluminescence immunoassay (ELICA)

NCT ID: NCT02890238 Recruiting - Infertility Clinical Trials

Sildenafil Effect After Ovulation Induction

Start date: August 2016
Phase: Phase 4
Study type: Interventional

100 women with infertility classified into 2 groups. Group A: Included 50 women who will be given clomiphene citrate 50mg (clomid) orally 2 times/day from 2rd-7th day of the cycle and sildeaynafil citrate 20mg tab from 7th-11th day of the same cycle orally 3 times/day. Group B: Included 50 women who will be given clomiphene citrate 50mg (clomid) orally 2 times/day from 2rd-7th day of the cycle and placebo tablets from 7th-11th day of the same cycle orally 3 times/day.